“Budget Impact Analysis of the Use of Daclatasvir in Italy for the Treatment of Hepatitis C Virus (HCV) Genotype 3 Patients”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 17, no. 1, Mar. 2016, pp. 7-12, https://doi.org/10.7175/fe.v17i1.1225.